Vertex One Asset Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Vertex One Asset Management’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-29,200	Closed	-$1.13M	–	162
2017 Q4	$1.13M	Hold	29,200	–	–	0.19%	78
2017 Q3	$1.14M	Buy	+29,200	New	+$1.07M	0.19%	79

Other funds holding NDRM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Vertex One Asset Management's NDRM Position: Q1 2018 in Review

Vertex One Asset Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q1 2018, closing a stake of 29,200 shares — an estimated $1.13M sold.

Vertex One Asset Management first reported a position in NDRM in Q3 2017 and held it in 2 quarters. The position peaked at $1.14M in Q3 2017. 2 funds tracked by Wall St. Rank hold NDRM as of Q1 2018.

Vertex One Asset Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q1 2018 after selling out during the quarter.
Vertex One Asset Management sold 29,200 NeuroDerm Ltd. Ordinary Shares shares in Q1 2018, an estimated $1.13M.
Vertex One Asset Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 2 quarters.
Vertex One Asset Management's NeuroDerm Ltd. Ordinary Shares position peaked at $1.14M in Q3 2017.
2 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q1 2018.

Based on Vertex One Asset Management's 13F filing for Q1 2018, filed 4 May 2018.